Featured Exhibitors

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

  • Screea is an universal cashback loyalty app which allows users to earn and spend loyalty points at partner merchants globally

    Screea

  • Rosetta.ai provides an end-to-end retention solution for small and medium e-commerce. We use 14 AI agents which can adopt in entire consumer journey to analyze consumer preferences, predict inventory, and recommend products for online and offline. So far, Rosetta.ai focuses on apparel, travel, and food e-commerces and served more than million consumers from more than 8 countries.

    Rosetta.ai

  • Instant NanoBiosensors Co., Ltd (INB) was founded in 2016 with offices located at Wilmington, Delaware USA and Taipei, Taiwan. We are the ONLY ONE company which provides Light-Sensing Biomarker Analyzer based on patented FOPPR (Optic Particle Plasmon Resonance) technology with assays combining wide linear range (~5 orders), ultra-sensitivity (~fg/ml ) and high specificity (double confirm), as well as the benefits of being instant, simple and accurate. Based on over 10 years of R&D accumulated experience by incorporating microfluidics, biology, chemistry and optoelectronics know-how, we have successfully applied FOPPR technology to develop the world’s first Light-Sensing Biomarker Analyzer with inspection chips of high specificity and sensitivity in Aug 2018. Moreover, we have officially obtained over 30 international patents and released 13 international publications. With only 1 drop of blood, 3 step-applications and 5 minutes to get the result, the platform can fit into the mainstream healthcare system to provide early stage screening tests and monitoring for patient’s conditions during and after treatment. In addition, the latest hand-held Light-Sensing Biomarker Analyzer for Point-of-Care Testing (POCT) is expected to be put on the market in Q1 2020. In the future, inspection analysis for disease biomarker of the patient can be conducted by using hand-held inspection device, while the relevant data may be uploaded to the backend diagnosis cloud platform to realize the vision of “instantaneous inspection” to help the patients reach the goal of further diagnosis and self-healthcare.

    Instant NanoBiosensors Co., Ltd

Exhibitors

  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd
  • Screea
  • Rosetta.ai
  • Taiwan Startup Stadium
  • OMNIEYES CO., LTD
  • Tsaitung Agriculture
  • Instant NanoBiosensors Co., Ltd

#Taiwanrocks Startup news

StartupNews
StartupNewsImg
StartupNewsImg
StartupNewsImg
StartupNewsImg
StartupNewsImg
Powered bysa-logo